import type { Metadata } from 'next'
import Image from 'next/image'
import Link from 'next/link'
import { buildPageMetadata } from '../../../../src/lib/seo'
import AuthorityJsonLd from '@/components/seo/AuthorityJsonLd'
import AuthorityBreadcrumbs from '@/components/navigation/AuthorityBreadcrumbs'
import LegacyGuideFAQ from '@/components/LegacyGuideFAQ'
import LegacyGuideQuickAnswer from '@/components/LegacyGuideQuickAnswer'
import References from '@/components/References'
import EmailCapture from '../../../../components/EmailCapture'

export const metadata: Metadata = buildPageMetadata({
  title: 'Melatonin for Circadian Timing, Sleep Onset & Maintenance (2026)',
  description:
    'Evidence-first melatonin guide separating circadian clock shifting, sleep-onset latency, sleep maintenance, prolonged-release formulations, chronic insomnia, jet lag, timing, safety, and product variability.',
  path: '/guides/other/melatonin-dosage-guide/',
  openGraphType: 'article',
})

const FAQS = [
  {
    question: 'Is melatonin mainly a sleep supplement or a circadian supplement?',
    answer:
      'Both descriptions can be relevant, but the circadian role is especially important. Melatonin is a biological timing signal, and appropriately timed exogenous melatonin can shift sleep-wake timing in circadian disorders such as delayed sleep-wake phase disorder and can help with jet lag [8,9]. That is a different use from treating chronic insomnia as a general sedative.',
  },
  {
    question: 'What is the best dose of melatonin for sleep?',
    answer:
      'There is no single evidence-based melatonin dose for every sleep problem. Dose, timing, age, formulation, and indication all matter. A 2024 dose-response meta-analysis of 26 randomized trials found pooled sleep-onset and total-sleep-time effects peaking around 4 mg/day, with administration timing also influencing outcomes [3]. That is a meta-analytic pattern across heterogeneous studies, not a universal personal protocol.',
  },
  {
    question: 'Is melatonin better for falling asleep or staying asleep?',
    answer:
      'The evidence is more consistent for changing sleep timing and modestly shortening sleep-onset latency than for fixing repeated awakenings. Prolonged-release melatonin has shown small improvements in some adult-insomnia sleep-onset and sleep-efficiency outcomes, but that does not establish melatonin as a reliable sleep-maintenance treatment [10]. Persistent nighttime awakenings can have causes such as sleep apnea, pain, reflux, alcohol, medications, menopause symptoms, or other sleep disorders.',
  },
  {
    question: 'Does melatonin work for chronic insomnia?',
    answer:
      'Melatonin can affect sleep timing and may modestly change some sleep outcomes, but the American Academy of Sleep Medicine pharmacologic guideline suggests not using melatonin for routine treatment of adult sleep-onset or sleep-maintenance insomnia [2]. A separate AASM behavioral guideline strongly recommends multicomponent CBT-I for chronic insomnia [5].',
  },
  {
    question: 'Does melatonin help jet lag?',
    answer:
      'Yes, there is direct randomized-trial evidence for jet lag. A Cochrane review found benefit when melatonin was taken near target bedtime after crossing multiple time zones, while emphasizing that timing matters and poorly timed use can delay adaptation [8]. Travel direction, destination bedtime, and light exposure still matter.',
  },
  {
    question: 'Is melatonin safe for children?',
    answer:
      'Short-term use may help selected pediatric sleep problems, but long-term safety remains uncertain. A 2023 systematic review found more non-serious adverse events with melatonin and very limited long-term developmental evidence [7]. The American Academy of Sleep Medicine advises parents to discuss melatonin with a pediatric health professional and to store it securely [4].',
  },
]

const MELATONIN_REFS = [
  {
    n: 1,
    text: 'National Center for Complementary and Integrative Health. Melatonin: What You Need To Know.',
    url: 'https://www.nccih.nih.gov/health/melatonin-what-you-need-to-know',
  },
  {
    n: 2,
    text: 'Sateia MJ, et al. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults. J Clin Sleep Med. 2017;13:307-349. PMID 27998379.',
    url: 'https://pubmed.ncbi.nlm.nih.gov/27998379/',
  },
  {
    n: 3,
    text: 'Cruz-Sanabria F, et al. Optimizing the Time and Dose of Melatonin as a Sleep-Promoting Drug: systematic review and dose-response meta-analysis. J Pineal Res. 2024;76:e12985. PMID 38888087.',
    url: 'https://pubmed.ncbi.nlm.nih.gov/38888087/',
  },
  {
    n: 4,
    text: 'American Academy of Sleep Medicine. Health Advisory: Melatonin Use in Children and Adolescents.',
    url: 'https://aasm.org/advocacy/position-statements/melatonin-use-in-children-and-adolescents-health-advisory/',
  },
  {
    n: 5,
    text: 'Edinger JD, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: AASM clinical practice guideline. J Clin Sleep Med. 2021;17:255-262. PMID 33164742.',
    url: 'https://pubmed.ncbi.nlm.nih.gov/33164742/',
  },
  {
    n: 6,
    text: 'Cohen PA, et al. Quantity of Melatonin and CBD in Melatonin Gummies Sold in the US. JAMA. 2023;329:1401-1402. PMID 37097362.',
    url: 'https://pubmed.ncbi.nlm.nih.gov/37097362/',
  },
  {
    n: 7,
    text: 'Händel MN, et al. Short- and long-term adverse effects of melatonin treatment in children and adolescents: systematic review and GRADE assessment. EClinicalMedicine. 2023;61:102083. PMID 37483551.',
    url: 'https://pubmed.ncbi.nlm.nih.gov/37483551/',
  },
  {
    n: 8,
    text: 'Herxheimer A, Petrie KJ. Melatonin for the prevention and treatment of jet lag. Cochrane Database Syst Rev. 2002;CD001520. PMID 12076414.',
    url: 'https://pubmed.ncbi.nlm.nih.gov/12076414/',
  },
  {
    n: 9,
    text: 'van Geijlswijk IM, et al. The use of exogenous melatonin in delayed sleep phase disorder: a meta-analysis. Sleep. 2010;33:1605-1614. PMID 21120122.',
    url: 'https://pubmed.ncbi.nlm.nih.gov/21120122/',
  },
  {
    n: 10,
    text: 'Efficacy of melatonin and ramelteon for the acute and long-term management of insomnia disorder in adults: systematic review and meta-analysis. Sleep Med Rev. 2023. PMID 37434463.',
    url: 'https://pubmed.ncbi.nlm.nih.gov/37434463/',
  },
  {
    n: 11,
    text: 'Iyer S, et al. Exogenous Melatonin and Sleep Quality: A Scoping Review of Systematic Reviews. J Clin Pharmacol. 2026;66:e70115. PMID 41014554.',
    url: 'https://pubmed.ncbi.nlm.nih.gov/41014554/',
  },
]

const evidenceCards = [
  {
    title: 'Circadian timing',
    evidence:
      'Melatonin can shift biological and sleep timing when administered in an appropriately timed circadian context. In a delayed-sleep-phase meta-analysis, melatonin advanced endogenous melatonin onset and clock sleep onset and shortened sleep-onset latency [9].',
    boundary:
      'A clock-shifting intervention is timing-sensitive. A fixed “take X mg at bedtime” rule can miss the actual circadian target, and light exposure is another major timing signal.',
  },
  {
    title: 'Sleep onset',
    evidence:
      'Meta-analytic evidence supports modest reductions in sleep-onset latency in some populations, and administration timing changes the observed effect [3,10].',
    boundary:
      'A statistically shorter sleep-onset latency does not prove that melatonin treats the cause of chronic insomnia or that one pooled dose is optimal for an individual.',
  },
  {
    title: 'Sleep maintenance',
    evidence:
      'Prolonged-release melatonin has produced small improvements in some adult-insomnia outcomes, including sleep efficiency, but effects are modest and heterogeneous [10,11].',
    boundary:
      'Repeated awakenings are not automatically a melatonin problem. Sleep apnea, pain, reflux, alcohol, medications, restless legs, and other conditions can produce sleep-maintenance symptoms.',
  },
  {
    title: 'Chronic insomnia',
    evidence:
      'Melatonin can change sleep timing and may modestly affect selected outcomes, but AASM suggests against routine melatonin treatment for adult sleep-onset or sleep-maintenance insomnia [2].',
    boundary:
      'CBT-I has a strong AASM recommendation for chronic insomnia [5]. Persistent insomnia deserves evaluation rather than repeated supplement escalation.',
  },
]

const decisionRows = [
  {
    situation: 'Bedtime keeps drifting later / delayed body clock',
    nextStep:
      'Ask whether the problem is circadian timing rather than sedation. Melatonin and light are timing signals; delayed sleep-wake phase evidence is not the same as ordinary insomnia evidence [9].',
  },
  {
    situation: 'Main problem is falling asleep',
    nextStep:
      'Sleep-onset latency is one of the outcomes where melatonin has the clearest modest signal, but caffeine, light, schedule, stress, sleep opportunity, and circadian delay can all change the interpretation [3].',
  },
  {
    situation: 'Main problem is waking repeatedly',
    nextStep:
      'Do not assume an immediate-release sleep-onset product will fix maintenance insomnia. Prolonged-release evidence is modest, and repeated awakenings warrant a cause-focused evaluation [10].',
  },
  {
    situation: 'Chronic insomnia lasting weeks or months',
    nextStep:
      'Prioritize CBT-I and evaluation for sleep apnea, restless legs, medication effects, mood/anxiety, pain, and circadian problems rather than escalating melatonin [2,5].',
  },
  {
    situation: 'Jet lag',
    nextStep:
      'Treat melatonin as a timing signal. Destination bedtime, travel direction, and light exposure change the plan; the evidence supports near-target-bedtime use rather than one universal dose schedule [8].',
  },
  {
    situation: 'Child or teenager',
    nextStep:
      'Discuss the decision with a pediatric health professional. Long-term developmental safety remains uncertain, and secure storage matters [4,7].',
  },
]

export default function MelatoninDosingPage() {
  return (
    <div className="container-page py-10 space-y-10">
      <AuthorityJsonLd
        title="Melatonin for Circadian Timing, Sleep Onset and Maintenance"
        description="Evidence-first review separating circadian clock shifting, sleep onset, sleep maintenance, formulation, insomnia, jet lag, pediatric safety, and product-label variability."
        url="https://thehippiescientist.net/guides/other/melatonin-dosage-guide"
        type="MedicalWebPage"
        citationUrls={MELATONIN_REFS.map((ref) => ref.url)}
      />
      <AuthorityBreadcrumbs
        items={[
          { label: 'Home', href: '/' },
          { label: 'Guides', href: '/guides/' },
          { label: 'Melatonin Evidence' },
        ]}
      />

      <section className="space-y-5 max-w-4xl">
        <p className="eyebrow-label">Evidence Review · 11 References · Updated August 22, 2026</p>
        <h1 className="text-5xl font-bold tracking-tight text-ink">Melatonin: Circadian Timing Is Not the Same as Treating Insomnia</h1>
        <p className="text-lg leading-8 text-muted">
          Melatonin is both a sleep-related hormone and a <strong>circadian timing signal</strong>. That is why “best melatonin dose,” “circadian supplement,” “help me fall asleep,” and “help me stay asleep” are not interchangeable questions. The indication, timing, formulation, age, and light environment can matter as much as the number on the label.
        </p>
        <figure className="mt-6">
          <div className="overflow-hidden rounded-2xl border border-brand-900/10 shadow-sm bg-white">
            <Image
              src="/images/guides/melatonin-dosage-guide.jpg"
              alt="Melatonin supplement beside a sleep mask and clock for a circadian timing evidence review"
              width={1536}
              height={1024}
              priority
              className="w-full h-auto"
            />
          </div>
          <figcaption className="mt-3 text-center text-sm text-muted">
            With melatonin, the clock problem, sleep symptom, timing, and formulation all change the evidence question.
          </figcaption>
        </figure>
      </section>

      <LegacyGuideQuickAnswer referencesHref="#references">
        <p>
          If the problem is a <strong>shifted body clock</strong>, melatonin has direct circadian evidence: delayed-sleep-phase trials show advances in biological and sleep timing [9], and jet-lag trials support appropriately timed use [8]. If the problem is <strong>adult chronic insomnia</strong>, the evidence is weaker: some analyses find small sleep-onset or prolonged-release sleep-efficiency effects [3,10], while AASM suggests against routine melatonin treatment for adult sleep-onset or sleep-maintenance insomnia and strongly recommends CBT-I [2,5]. A 2026 review of systematic reviews reinforces how heterogeneous the evidence remains across populations and outcomes [11].
        </p>
      </LegacyGuideQuickAnswer>

      <section className="grid gap-5 md:grid-cols-2">
        {evidenceCards.map((card) => (
          <article key={card.title} className="card-premium p-6 space-y-4">
            <h2 className="text-xl font-semibold text-ink">{card.title}</h2>
            <div>
              <p className="text-xs font-bold uppercase tracking-wider text-emerald-800">What the evidence suggests</p>
              <p className="mt-2 text-sm leading-6 text-muted">{card.evidence}</p>
            </div>
            <div>
              <p className="text-xs font-bold uppercase tracking-wider text-amber-800">Decision boundary</p>
              <p className="mt-2 text-sm leading-6 text-muted">{card.boundary}</p>
            </div>
          </article>
        ))}
      </section>

      <section id="melatonin-decision-table" data-answer-engine-table="true" className="space-y-4 max-w-5xl scroll-mt-24">
        <h2 className="text-3xl font-semibold tracking-tight text-ink">Sleep onset vs maintenance vs circadian delay</h2>
        <p className="text-sm leading-7 text-muted max-w-4xl">
          “Sleep supplement” is too broad to be clinically useful. Falling asleep late because the internal clock is delayed is different from being sleepy at the right time but unable to fall asleep, and both are different from repeated nighttime awakenings.
        </p>
        <div className="overflow-x-auto rounded-2xl border border-brand-900/10 bg-white/90 dark:border-white/10 dark:bg-white/5">
          <table className="min-w-[800px] w-full text-left text-sm">
            <caption className="sr-only">Melatonin decision guide separating circadian timing, sleep onset, sleep maintenance, insomnia, and jet lag</caption>
            <thead>
              <tr className="border-b border-brand-900/10 text-ink">
                <th scope="col" className="p-4">Situation</th>
                <th scope="col" className="p-4">Better evidence question</th>
              </tr>
            </thead>
            <tbody className="divide-y divide-brand-900/10 text-muted">
              {decisionRows.map((row) => (
                <tr key={row.situation}>
                  <th scope="row" className="p-4 font-semibold text-left text-ink">{row.situation}</th>
                  <td className="p-4 leading-6">{row.nextStep}</td>
                </tr>
              ))}
            </tbody>
          </table>
        </div>
      </section>

      <section className="card-premium p-6 space-y-4 max-w-4xl">
        <p className="eyebrow-label">Formulation boundary</p>
        <h2 className="text-2xl font-semibold tracking-tight text-ink">Immediate-release and prolonged-release are not the same intervention</h2>
        <p className="text-sm leading-7 text-muted">
          A formulation designed to release melatonin quickly is conceptually closer to a sleep-onset or timing intervention, whereas prolonged-release products are designed to extend exposure across the night. But formulation theory is not proof of clinical superiority. In adult insomnia, prolonged-release melatonin has shown only <strong>small average improvements</strong> in selected sleep-onset and sleep-efficiency outcomes [10].
        </p>
        <p className="text-sm leading-7 text-muted">
          This is why a generic “sleep onset supplement vs sleep maintenance supplement” ranking can mislead. The better approach is to identify the symptom and cause first, then ask whether the studied formulation actually matches that problem.
        </p>
      </section>

      <section className="card-premium p-6 space-y-4 max-w-4xl">
        <h2 className="text-2xl font-semibold tracking-tight text-ink">Product quality changes the dosing conversation</h2>
        <p className="text-sm leading-7 text-muted">
          In the United States, melatonin is sold as a dietary supplement rather than an FDA-approved insomnia drug. In a 2023 analysis of 25 melatonin gummy products, 22 were inaccurately labeled; among products containing detectable melatonin, measured content ranged from 74% to 347% of the labeled amount [6]. That means a label dose is not always the dose a person actually receives.
        </p>
        <p className="text-sm leading-7 text-muted">
          A precise-looking milligram rule can therefore create false confidence when formulation quality, circadian timing, and the actual sleep diagnosis are still uncertain.
        </p>
      </section>

      <section className="rounded-2xl border border-amber-900/15 bg-amber-50/70 p-6 text-amber-950 dark:border-amber-200/20 dark:bg-amber-950/20 dark:text-amber-50">
        <p className="text-xs font-bold uppercase tracking-[0.16em]">Safety boundary</p>
        <h2 className="mt-2 text-2xl font-semibold">Children and long-term use need extra caution</h2>
        <p className="mt-3 text-sm leading-7">
          Short-term melatonin is generally associated with few serious adverse events, but robust long-term safety data remain limited [1]. In children and adolescents with chronic insomnia, a 2023 systematic review found an increase in non-serious adverse events and very limited, low-certainty evidence about longer-term pubertal development [7]. AASM advises parents to discuss melatonin with a pediatric health professional and keep supplements out of children&rsquo;s reach [4]. Persistent sleep problems should be evaluated rather than managed indefinitely by escalating a supplement dose.
        </p>
        <div className="mt-5 flex flex-wrap gap-3">
          <Link href="/safety-checker/" className="rounded-full bg-amber-900 px-4 py-2 text-sm font-semibold text-white transition hover:bg-amber-950 dark:bg-amber-100 dark:text-amber-950">
            Check supplement interactions
          </Link>
          <Link href="/guides/sleep/" className="rounded-full border border-amber-900/20 px-4 py-2 text-sm font-semibold text-amber-950 transition hover:bg-white/60 dark:border-amber-100/30 dark:text-amber-50">
            Browse sleep guides
          </Link>
        </div>
      </section>

      <div id="references" className="scroll-mt-24">
        <References refs={MELATONIN_REFS} />
      </div>
      <LegacyGuideFAQ pagePath="/guides/other/melatonin-dosage-guide/" questions={FAQS} referencesHref="#references" />
      <EmailCapture
        headline="Get evidence reviews like this"
        description="Sleep and circadian evidence separated by the problem actually being treated."
        ctaLabel="Get the evidence"
        location="guide-melatonin-dosing"
      />
      <div className="pt-4 border-t border-brand-900/10 flex items-center justify-between">
        <Link href="/guides/" className="inline-flex rounded-full border border-brand-900/10 bg-[var(--surface-card)] px-4 py-2 text-sm font-bold text-ink transition hover:bg-brand-50">
          ← Back to guides
        </Link>
        <Link href="/guides/sleep/best-supplements-for-sleep/" className="text-sm font-bold text-brand-800 hover:underline">
          Best sleep supplements →
        </Link>
      </div>
    </div>
  )
}
